Geoffrey R. Oxnard M.D.

Dana-Farber Cancer Institute, Harvard Medical School

How Liquid Biopsies Help Understanding of Resistance to Chemotherapy

Geoffrey R. Oxnard, M.D., Assistant Professor, Dana-Farber Cancer Institute, Harvard Medical School, discusses his research into resistance development of non-small cell lung cancers to Osimertinib. Hear how the detection of key mutations in cell-free DNA from liquid biopsies helps improve understanding of resistance development, as well as inform treatment decisions. In the future Oxnard hopes his research will help to provide personalized treatment strategies for cancer patients.



LIKE 0
Geoffrey R. Oxnard M.D.
Precision Medicine

Geoffrey R. Oxnard M.D.

Biography

Geoffrey R. Oxnard is Assistant Professor of Medicine at Harvard Medical School. More

Geoffrey R. Oxnard M.D.

Dana-Farber Cancer Institute, Harvard Medical School

Geoffrey R. Oxnard is Assistant Professor of Medicine at Harvard Medical School. He is a medical oncologist specializing in the treatment of patients with non-small cell lung cancer. His research focuses on strategies for improved understanding and treatment of lung cancer. He has several specific areas of research focus, which include: Acquired resistance to targeted therapies (EGFR, ALK, etc) in lung cancer; targeted therapies and clinical trial design for rare lung cancer genotypes; the biology of lung cancer diagnosed at a young age (under the age of 50); familial lung cancer in non-smokers; noninvasive lung cancer genotyping through analysis of free floating DNA in the blood.